Defining the role of overactive bladder treatments in men with lower urinary tract symptoms

Nature Clinical Practice Urology

Volumn 4, Issue 4, 2007, Pages 174-175

  Lemack, Gary E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; PLACEBO; STEROID 5ALPHA REDUCTASE INHIBITOR; TAMSULOSIN; TOLTERODINE;

BLADDER NECK STENOSIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DETRUSOR DYSSYNERGIA; DRUG SAFETY; HUMAN; LOWER URINARY TRACT SYMPTOM; MONOTHERAPY; NOCTURIA; OVERACTIVE BLADDER; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; REVIEW; TRANSURETHRAL RESECTION; UNSPECIFIED SIDE EFFECT; URGE INCONTINENCE; URINARY FREQUENCY; URINARY URGENCY; URINE RETENTION; URODYNAMICS;

AGED; HUMANS; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PROGNOSIS; PROSTATIC HYPERPLASIA; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; URINALYSIS; URINARY BLADDER NECK OBSTRUCTION; URINARY BLADDER, OVERACTIVE; URINARY TRACT INFECTIONS; URODYNAMICS;

EID: 34147125502     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro0754     Document Type: Review

References (9)

1. Machino R et al. (2002) Detrusor instability with equivocal obstruction: A predictor of unfavorable symptomatic outcomes after transurethral prostatectomy. Neurourol Urodyn 21: 444-449
2. Abrams PH et al. (1979) The results of prostatectomy: A symptomatic and urodynamic analysis of 152 patients. J Urol 121 640-642
3. Abrams P et al. (2006) Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction. J Urol 175: 999-1004
4. Kaplan SA et al. (2005) Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia. J Urol 174: 2273-2275
5. Chapple C et al. (2005) The effects of antimuscarinic treatments in overactive bladder: A systematic review and meta-analysis. Eur Urol 48: 5-26
6. Athanasopoulos A et al. (2003) Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: A prospective, randomized, controlled study. J Urol 169: 2253-2256
7. Lee JY et al. (2004) Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder. BJU Int 94: 817-820
8. Roehrborn CG et al. (2006) Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence. BJU Int 97: 1003-1006
9. Kaplan SA et al. (2006) Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: A randomized controlled trial. JAMA 296: 2319-2328